Explore the full directors' dealings record of Health In Tech, Inc., a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Health In Tech, Inc. has logged 2 public disclosures. Market capitalisation: €91.8m. The latest transaction was reported on 20 April 2026 — Retenue fiscale. Among the most active insiders: Johnson Tim Donald. The full history is accessible without an account.
2 of 2 declarations
Health In Tech, Inc. (ticker: HIT) is a U.S.-listed insurtech company traded on the American NYSE/NASDAQ market, and incorporated in the United States in the State of Nevada. The company is headquartered in Stuart, Florida, and positions itself at the intersection of health insurance and technology, with a business model focused on simplifying, automating, and accelerating the sales and servicing workflows for self-funded health plans and related insurance solutions. According to its SEC filings, HIT was incorporated in November 2021 and was formed to consolidate several standalone businesses into a single operating structure, including Stone Mountain Risk (SMR), Health Intelligence Card (Hi Card), and International Captive Exchange (ICE). ([sec.gov](https://www.sec.gov/Archives/edgar/data/0002019505/000121390026034211/ea0283147-10k_health.htm?utm_source=openai)) Operationally, Health In Tech describes itself as an AI-enabled insurance technology platform and marketplace aimed at improving healthcare-industry processes through vertical integration, process simplification, and automation. Its proprietary eDIYBS platform is marketed to streamline quoting and binding for self-funded health plans for larger employers and level-funded plans for small and mid-sized businesses. HIT primarily serves brokers, third-party administrators (TPAs), carriers, and managing general underwriters (MGUs), which places it closer to a technology-enabled distribution and workflow platform than a traditional carrier. ([sec.gov](https://www.sec.gov/Archives/edgar/data/2019505/000121390026047605/ea0287599-s3_health.htm?utm_source=openai)) From a competitive standpoint, the company’s value proposition centers on reducing sales-cycle friction in a complex, fragmented, and administratively intensive U.S. health-benefits market. HIT states that it operates across all 50 U.S. states, giving it national reach even though its corporate base and management functions are concentrated in Florida. Its core offerings include self-funded health-plan enablement, quote-and-bind workflows, stop-loss solutions through Stone Mountain Risk, and ancillary product lines that broaden the platform’s scope, including critical illness, accident, dental, vision, term life, and GAP coverage. ([healthintech.com](https://healthintech.com/about/?utm_source=openai)) Recent developments suggest an active growth and capital-markets agenda. In SEC filings and company communications, HIT has highlighted commercial expansion, additional ancillary products, and brand-building initiatives such as its 2026 hitDavos event. The company also disclosed a PIPE financing in March 2026 and has been the subject of Form 4 insider-transaction filings, underscoring continued shareholder activity and market attention. For investors, HIT should be viewed as a U.S. small-cap insurtech with an offensive growth profile, exposed to the expansion of self-funded healthcare plans, but also to execution risk, commercial dependence, and potential dilution. ([sec.gov](https://www.sec.gov/Archives/edgar/data/2019505/000121390026034716/ea0283456-8k_health.htm?utm_source=openai))